For the selection of high-risk individuals, it is important to note that we found no difference in the odds and AAO for AD for APOE ɛ4 heterozygotes with the highest PRS compared to APOE ɛ4 homozygotes with the lowest PRS. The gene discussed is APOE; the disease is Alzheimer disease.